The deal will raise £143.4m for the company and £21.7m for selling shareholders. The Financial Times also reports that Darktrace could raise another £25m through an overallotment option if there is demand from investors. It puts the company on course for the higher valuation it had hoped for, having opened at around £1bn below its initial target according to FT. "Our company is deeply rooted in the UK's tradition of scientific and mathematic research so we are especially proud to be listing on the London Stock Exchange," Poppy Gustafsson, Darktrace's CEO said. "We owe much gratitude to the Invoke team for their pivotal role in the vision, technology, positioning and operational input in the early years without which today's success would not have been possible."